Washington, D.C. 20549



Proxy Statement Pursuant to Section 14(a)

of the Securities Exchange Act of 1934


Filed by the Registrant

Filed by a Party other than the Registrant

Check the appropriate box:

Preliminary Proxy Statement


Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))


Definitive Proxy Statement


Definitive Additional Materials


Soliciting Material under §240.14a-12

Adaptive Biotechnologies Corporation

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)


Payment of Filing Fee (Check the appropriate box):

No fee required.


Fee paid previously with preliminary materials.


Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.







P.O. BOX 8016, CARY, NC 27512-9903 Adaptive Biotechnologies Corporation Important Notice Regarding the Availability of Proxy Materials Shareholders Meeting to be held on June 10, 2022 For Shareholders of record as of April 14, 2022 This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting. To view the proxy materials, and to obtain directions to attend the meeting, go to: To vote your proxy while visiting this site, you will need the 12 digit control number in the box below. Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the internet. For a convenient way to view proxy materials and VOTE go to Have the 12 digit control number located in the shaded box above available when you access the website and follow the instructions. If you want to receive a paper or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year's meeting, you must make this request on or before May 31, 2022. To order paper materials, use one of the following methods. TELEPHONE(866) 648-8133* When requesting via the Internet or telephone you will need the 12 digit control number located in the shaded box above. * If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located above) in the subject line. No other requests, instructions OR other inquiries should be included with your e-mail requesting material. Adaptive Biotechnologies Corporation Annual Meeting of Shareholders Meeting Type: Date: Time: Place: Friday, June 10, 2022 9:00 AM, Pacific Time Annual Meeting to be held live via the Internet - please visit for more details. You must register to attend the meeting online and/or participate at SEE REVERSE FOR FULL AGENDA







Adaptive Biotechnologies Corporation Annual Meeting of Shareholders THE BOARD OF DIRECTORS RECOMMENDS A VOTE: FOR ON PROPOSALS 1, 2 AND 3 PROPOSAL 1. To elect three Class III director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2025 annual meeting of shareholders. 1.01 Chad Robins 1.02 Kevin Conroy 1.03 Dr. Michael Pellini 2. To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement. 3. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our year ending December 31, 2022. 4. To conduct any other business properly brought before the meeting or any adjournments thereof.